Breakthrough data from Vatiquinone trials propels PTC Therapeutics stock to 52-week high

PTC Therapeutics Inc. (NASDAQ: PTCT) is experiencing significant momentum within the biotechnology sector following a surge in its stock price to a 52-week high of ... Read More